RxDoctor Payments Data

Percy Lee, MD

Radiation Oncology · Irvine, CANPI 1447442504

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $90,925 of the $124,599 with a category attached, or 73.0%. 18 manufacturers reported payments, led by Viewray Technologies Inc at 31.7% of the total. 2025 is the largest year on record at $36,827, 2.0 times the $18,134 reported in 2019. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$124,599in general payments, 2019–2025

Across 118 payments — averaging $1055.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viewray Technologies Inc$39K
  • AstraZeneca$33K
  • GE HealthCare$22K
  • Varian Medical Systems, Inc.$8K
  • F. Hoffmann-la Roche AG$8K
  • Siemens Medical Solutions USA, Inc.$4K
  • plus $9K from 12 others
$2,292,531in research payments, 2019–2025

Across 19 payments — averaging $120,660 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$2.3M
  • Siemens Medical Solutions USA, Inc.$23K
  • Genentech, Inc.$11K
  • Viewray Technologies Inc$9K

What the payments were for

  • Consulting fees$90,92573%
  • Speaking & faculty fees$25,09620%
  • Travel & lodging$4,1943%
  • Food & beverage$4,3844%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$124,599 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$568,934
Medicare patients
312
Services billed
4,612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl47$269

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →